Leonard Schleifer

Chief Executive Officer at REGENERON PHARMACEUTICALS, INC.

Net worth: 2 331 M $ as of 30/03/2024

71 year

Consumer Services

Health Technology

Profile

Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REGENERON PHARMACEUTICALS, INC. 82.61%	10/04/2023	1,726,565 ( 82.61% )	1 662 M $	30/03/2024
REGENERON PHARMACEUTICALS, INC. 0.64%	10/12/2023	695,330 ( 0.64% )	669 M $	30/03/2024

Leonard Schleifer active positions

Companies	Position	Start
REGENERON PHARMACEUTICALS, INC.	Chief Executive Officer	07/01/1988
Regeneron Ireland DAC Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies.	Chief Executive Officer	31/12/2012

All active positions of Leonard Schleifer

Former positions of Leonard Schleifer

Companies	Position	End
Weill Cornell Medical College	Corporate Officer/Principal	-

See the detail of Leonard Schleifer's experience

Training of Leonard Schleifer

University of Virginia	Doctorate Degree
Cornell University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leonard Schleifer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
REGENERON PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Regeneron Ireland DAC Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies.	Health Technology